JPH0999036A - Vessel for medical treatment - Google Patents
Vessel for medical treatmentInfo
- Publication number
- JPH0999036A JPH0999036A JP7259047A JP25904795A JPH0999036A JP H0999036 A JPH0999036 A JP H0999036A JP 7259047 A JP7259047 A JP 7259047A JP 25904795 A JP25904795 A JP 25904795A JP H0999036 A JPH0999036 A JP H0999036A
- Authority
- JP
- Japan
- Prior art keywords
- vessel
- container
- sheet
- produced
- transparency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004743 Polypropylene Substances 0.000 claims abstract description 38
- 238000002844 melting Methods 0.000 claims abstract description 15
- 230000008018 melting Effects 0.000 claims abstract description 15
- 229920001155 polypropylene Polymers 0.000 claims abstract description 12
- 239000003054 catalyst Substances 0.000 claims abstract description 6
- -1 polypropylene Polymers 0.000 claims description 14
- 239000012968 metallocene catalyst Substances 0.000 abstract description 6
- 229910052719 titanium Inorganic materials 0.000 abstract description 4
- 239000010936 titanium Substances 0.000 abstract description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 abstract description 3
- 238000009826 distribution Methods 0.000 abstract description 3
- 238000010828 elution Methods 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 12
- 229920000642 polymer Polymers 0.000 description 12
- 239000007788 liquid Substances 0.000 description 8
- 239000000306 component Substances 0.000 description 7
- 238000005192 partition Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000007789 sealing Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229920001684 low density polyethylene Polymers 0.000 description 4
- 239000004702 low-density polyethylene Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000005977 Ethylene Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 239000004902 Softening Agent Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000002815 homogeneous catalyst Substances 0.000 description 2
- 239000003978 infusion fluid Substances 0.000 description 2
- 229920000092 linear low density polyethylene Polymers 0.000 description 2
- 239000004707 linear low-density polyethylene Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 239000011954 Ziegler–Natta catalyst Substances 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229920001585 atactic polymer Polymers 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012611 container material Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000004049 embossing Methods 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 229910052735 hafnium Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000010102 injection blow moulding Methods 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000009740 moulding (composite fabrication) Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001748 polybutylene Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920002742 polystyrene-block-poly(ethylene/propylene) -block-polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 239000012748 slip agent Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Laminated Bodies (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は血液、薬液等医療分
野において扱われる液体を収容する容器、特にソフトバ
ッグに関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a container, particularly a soft bag, for containing a liquid handled in the medical field such as blood and liquid medicine.
【0002】[0002]
【従来の技術】採血、輸血、輸液等の医療分野において
用いられる容器の材料には安全性、衛生性の他、種々の
性能が要求され、なかでも柔軟性、透明性および耐熱性
(耐高圧蒸気滅菌性)やこれらのバランスは重視される
項目である。上記用途のポリマー素材には従来から軟質
ポリ塩化ビニルの他、エチレン−酢酸ビニルコポリマー
や低密度ポリエチレン(高圧法低密度ポリエチレンある
いはZiegler-Natta 触媒系線状低密度ポリエチレン)の
如きポリエチレン系ポリマーが主として使われている
が、軟質ポリ塩化ビニルでは可塑剤の溶出、廃棄処理な
どにおいて問題を生じることがある。エチレン−酢酸ビ
ニルコポリマーは透明性と柔軟性において通常の(酢酸
ビニル成分を含まない)低密度ポリエチレンに比してす
ぐれているが、耐熱性に劣り、放射線架橋などの耐熱化
処理を要する。また通常の低密度ポリエチレンにおいて
は柔軟性、透明性、耐熱性いずれも不十分であり、比較
的バランスのよいZiegler-Natta 触媒系線状低密度ポリ
エチレンでもこれらの要件を満たすのは難しい。2. Description of the Related Art Container materials used in the medical field such as blood sampling, blood transfusion, and liquid transfusion are required to have various performances in addition to safety and hygiene. Among them, flexibility, transparency and heat resistance (high pressure resistance) Steam sterilization) and their balance are important items. Conventionally, as the polymer material for the above-mentioned applications, in addition to soft polyvinyl chloride, polyethylene-based polymers such as ethylene-vinyl acetate copolymer and low-density polyethylene (high-pressure low-density polyethylene or Ziegler-Natta catalytic linear low-density polyethylene) have been mainly used. Although used, soft polyvinyl chloride may cause problems in elution and disposal of plasticizers. The ethylene-vinyl acetate copolymer is excellent in transparency and flexibility as compared with ordinary low-density polyethylene (containing no vinyl acetate component), but is inferior in heat resistance and requires heat treatment such as radiation crosslinking. In addition, ordinary low-density polyethylene has insufficient flexibility, transparency, and heat resistance, and it is difficult to meet these requirements even with a relatively balanced Ziegler-Natta catalyst linear low-density polyethylene.
【0003】また、ポリプロピレンも医療用容器に広く
使われているポリマーであり、その良好な耐熱性はポリ
エチレンに比してはるかに有利であり、透明性も比較的
すぐれているが、高剛性であり柔軟性に乏しく、また融
点が高いために熱シールしにくく、製袋性に難がある。
ポリプロピレンを柔軟化するために他のモノマー(例え
ばエチレン、ブテン−1)との共重合および柔軟化剤
(例えばスチレン系エラストマー)とのブレンドが代表
例であるが、前者では柔軟性を増すためにコモノマー量
を多くしたポリマーを容器(シート)にすると表面にべ
たつきの問題が生じる(低分子量成分や無定形成分に起
因)。また、後者ではブレンドにおいて柔軟剤導入時に
つきもののシート表面の粘着性増大によるブロッキング
の問題の他、シート形成性能低下による成形性・加工性
の低下、柔軟剤の高価格などのため制限を受けやすい。
なお、ここで言う「ポリプロピレン」は不均一系チタン
触媒で製造される通常の結晶性ポリプロピレンのことで
ある。Polypropylene is also a polymer widely used in medical containers. Its good heat resistance is far superior to that of polyethylene, and its transparency is relatively excellent, but it has high rigidity. It is poor in flexibility, and has a high melting point, which makes it difficult to perform heat sealing and has a difficulty in bag making.
Copolymerization with other monomers (for example, ethylene and butene-1) to soften polypropylene and blending with a softening agent (for example, styrenic elastomer) are typical examples. In the former, in order to increase flexibility, When a container (sheet) is made of a polymer containing a large amount of comonomer, the problem of stickiness on the surface occurs (due to low molecular weight components and amorphous components). In the latter case, in addition to the problem of blocking due to the increase in the tackiness of the sheet surface when introducing a softener in the blend, the moldability and processability are deteriorated due to the deterioration of the sheet forming performance, and the price of the softener is likely to be limited. .
The "polypropylene" referred to here is a normal crystalline polypropylene produced with a heterogeneous titanium catalyst.
【0004】[0004]
【発明が解決しようとする課題】本発明は従来技術の持
つ上述の如き諸問題のうちのポリプロピレン系医療容器
の欠点を解消すべくなされたものである。SUMMARY OF THE INVENTION The present invention has been made to solve the drawbacks of polypropylene-based medical containers among the above-mentioned problems of the prior art.
【0005】[0005]
【課題を解決するための手段】本発明者の検討で明らか
になったのは比較的低融点のメタロセン触媒系ポリプロ
ピレンの利用が課題解決につながることであり、メタロ
セン系触媒で製造され、かつ融点が140℃以下である
ポリプロピレン(以下M−PPと称す)を形成層として
含む医療用容器を要旨とする本発明に至った。メタロセ
ン系触媒で製造されるポリプロピレンは不均一系チタン
触媒で製造される「通常」のポリプロピレン(以下PP
と称す)に比し、均一系触媒の効果が発揮され、分子量
分布が非常に狭く、ランダム性に富み均一な分子構造を
とるので、透明性にすぐれ、低融点品の場合でも低分子
量物や不定形物(アタクチックポリマー)が非常に少な
いのでべたつきが無く溶出成分も微量であることは周知
の通りであり、融点が140℃以下と比較的低融点のM
−PPは必然的に柔軟性に富むことも明らかであるが、
その良好な透明性と柔軟性が高圧蒸気滅菌処理しても保
持されることが見出されたのである。Means for Solving the Problems What has been clarified in the study by the present inventors is that the use of a metallocene catalyst-based polypropylene having a relatively low melting point leads to the solution of the problems. The present invention is based on a medical container including polypropylene (hereinafter referred to as M-PP) having a temperature of 140 ° C or less as a forming layer. Polypropylene produced with a metallocene catalyst is a "normal" polypropylene produced with a heterogeneous titanium catalyst (hereinafter PP).
The effect of a homogeneous catalyst is exhibited, the molecular weight distribution is very narrow, and the random molecular structure is rich and uniform, resulting in excellent transparency and low molecular weight substances even in low melting point products. It is well known that the amount of amorphous material (atactic polymer) is very small, so that it is not sticky and the amount of eluted components is very small.
-Although it is clear that PP is naturally flexible,
It has been found that its good transparency and flexibility are retained even after autoclaving.
【0006】本発明におけるM−PPはKaminsky-Sinn
触媒(活性点の性質が同一という点に着目してシングル
サイト触媒あるいは均一系触媒とも言われる)とも呼ば
れるメタロセン触媒(一般にはZr, Hf, Tiなどの遷移金
属のシクロペンタジエニル系、インデニル系あるいはク
レオニル系化合物)を用いて製造されるポリプロピレン
のうち融点が140℃以下のものであり、アイソタクチ
ックのあるいはシンジオタクチックの立体規則性の度合
い、2,1−結合(頭−頭結合あるいは尾−尾結合)や
1,3−結合(トリメチレン結合)の含量が調節されて
製造される。またエチレン、ブテン−1、ヘキセン−
1、オクテン−1などのα−オレフィン類を少量(2〜
20モル%)共重合されたコポリマーであることもあ
る。M−PPの製法等については、例えば曽我和雄ほか
著「日本化学会編・新産業化学シリーズ・重合プロセス
技術)−ポリオレフィン」(大日本図書(株)1994
年発行)に述べられている。M-PP in the present invention is Kaminsky-Sinn
Metallocene catalysts, which are also called catalysts (also called single-site catalysts or homogeneous catalysts by focusing on the fact that the properties of active sites are the same) (generally, cyclopentadienyl-based and indenyl-based transition metals such as Zr, Hf, and Ti) Or polypropylene having a melting point of 140 ° C. or lower, the degree of isotactic or syndiotactic stereoregularity, 2,1-bond (head-head bond or It is produced by controlling the content of (tail-to-tail bond) or 1,3-bond (trimethylene bond). In addition, ethylene, butene-1, hexene-
1, small amounts of α-olefins such as octene-1 (2-
20 mol%) copolymerized copolymer. Regarding the production method of M-PP, for example, Kazuo Soga et al., “Chemical Society of Japan, New Industrial Chemistry Series, Polymerization Process Technology) -Polyolefin” (Dainippon Book Co., Ltd. 1994)
Published annually).
【0007】本発明におけるM−PPはその融点が14
0℃以下であることを要件とする。融点が140℃を超
えると剛性が高くなり柔軟性に乏しいからである。高圧
蒸気滅菌温度(通常、100〜121℃で行われる)を
も考慮すると好ましい融点は120〜135℃である。
この領域ではM−PPの曲げ弾性率は約4,000kg/c
m2以下であり、例えば自己排液性(点滴時に通常針がな
くても排液され得る性質)にすぐれた輸液容器(袋)を
提供する。そして成形性、成形物(容器シート)の力学
的性質などを考慮すると、温度230℃、荷重2,16
0gにおけるMFR(メルトフローレイト)が0.3〜
15より好ましくは0.5〜10であるのがよい。上述
の如く、本発明の医療用容器を形成するシートはM−P
Pを形成層として含むが、ここで形成層として含むと
は、シートがM−PP単独の層からなる場合およびM−
PPを少なくとも一層とし、他のポリマーを少なくとも
一層とする多層体である場合があるという意味である。
後者の場合は容器(シート)の力学的性質(強度、伸度
など)、成形性、熱シール性、ガス(酸素、炭酸ガス、
水蒸気など)バリアー性などを調節・改良するために採
用され、多層体を形成する上記「他のポリマー」として
はポリエチレン、ポリブテン−1、ポリ−4−メチルペ
ンテン−1、エチレン−ビニルアルコールコポリマー、
ポリエステル、ポリアミド、ポリウレタンなどが挙げら
れる。場合によっては「通常のPP」あるいは「融点が
140℃を超えるM−PP」の使用もあり得る。The melting point of M-PP in the present invention is 14
The requirement is 0 ° C or lower. This is because if the melting point exceeds 140 ° C., the rigidity becomes high and the flexibility is poor. Considering the high-pressure steam sterilization temperature (generally performed at 100 to 121 ° C), the preferable melting point is 120 to 135 ° C.
In this region, the bending elastic modulus of M-PP is about 4,000 kg / c.
Provided is an infusion container (bag) excellent in self-draining property (property of being able to be drained without a needle during infusion), which is not more than m 2 . Considering the moldability and mechanical properties of the molded product (container sheet), the temperature is 230 ° C and the load is 2,16.
MFR (melt flow rate) at 0 g is 0.3-
15 is more preferable, and 0.5 to 10 is more preferable. As described above, the sheet forming the medical container of the present invention is MP
P is included as a forming layer, and the inclusion of P as a forming layer here means that the sheet is composed of a layer of M-PP alone or M-PP.
This means that it may be a multilayer body in which PP is at least one layer and other polymer is at least one layer.
In the latter case, the mechanical properties (strength, elongation, etc.) of the container (sheet), moldability, heat sealability, gas (oxygen, carbon dioxide,
(Others such as water vapor) is adopted to adjust / improve barrier properties and the like, and as the above-mentioned "other polymer" forming a multilayer body, polyethylene, polybutene-1, poly-4-methylpentene-1, ethylene-vinyl alcohol copolymer,
Examples thereof include polyester, polyamide and polyurethane. In some cases, "normal PP" or "M-PP having a melting point of higher than 140 ° C" may be used.
【0008】ここで注意すべきは「他のポリマー」の厚
さである。すなわち本発明の趣旨である柔軟性と透明性
の発現のためには剛性の高いポリマーの場合にはその層
を薄くすることが好ましく、一層あたりの厚さは0.0
8mm以下さらに好ましくは0.05mm以下であるのがよ
い。また、シート全体の肉厚は0.05〜0.8mmさらに
好ましくは0.08〜0.6mm程度が適当である。本発明
において医療用容器とは血液等の体液保存用の薬液、輸
液、腹膜透析液等の薬液等医療において扱われる液体を
収容する容器を意味するが、かような製品は通常公知の
方法で得られる。すなわち、M−PPや他のポリマーを
流動開始温度以上の温度好ましくは160〜240℃で
Tダイやサーキュラーダイを介して押出し、得られたフ
ラット状のシート、チューブ状のシート、パリソンなど
についてサーモフォーミング、ブロー、裁断、熱シール
などの手法を適宜活用して所定の形状に加工すればよ
い。インジェクションブロー成形法を採用することも可
能である。シートは無延伸、延伸いずれでもよいが、シ
ール性を考慮すると無延伸状態の方がよい。また、シー
ト間のブロッキングを抑える目的で、特に上述の多層体
において、ポリエチレンのようなブロッキングしやすい
ポリマーを使った場合)、容器の内面や外面を粗面化
(エンボス加工)すること、ブロッキング防止剤やスリ
ップ剤を添加すること、本発明の趣旨を損わない範囲
で、他のポリマー、柔軟剤、無機フィラー、安定剤、着
色剤などを添加してもよい。なお、スチレン系エラスト
マー例えば、ブロック(ポリスチレン−エチレンブチレ
ンコポリマー−ポリスチレン)(SEBS)やブロック
(ポリスチレン−エチレンプロピレンコポリマー−ポリ
スチレン)(SEPS)を添加することを妨げるもので
ないことは言うまでもない。本発明は血液または血液成
分保存容器として、また生理食塩水、電解質液、デキス
トラン製剤、マンニトール製剤、糖類製剤、アミノ酸製
剤、脂肪乳剤などの輸液剤、あるいは腹膜透析液等の容
器として有用である。Of note here is the thickness of the "other polymer". That is, in the case of a polymer having high rigidity, it is preferable to make the layer thin in order to exhibit the flexibility and the transparency which are the gist of the present invention, and the thickness per layer is 0.0
It is preferably 8 mm or less, more preferably 0.05 mm or less. Further, the thickness of the entire sheet is preferably 0.05 to 0.8 mm, more preferably about 0.08 to 0.6 mm. In the present invention, the medical container means a container for storing a liquid to be treated in medicine such as a liquid medicine for storing body fluid such as blood, an infusion solution, a liquid medicine such as a peritoneal dialysis solution, and such a product is generally known. can get. That is, M-PP and other polymers are extruded through a T die or a circular die at a temperature above the flow initiation temperature, preferably 160 to 240 ° C., and the obtained flat sheet, tubular sheet, parison, etc. It may be processed into a predetermined shape by appropriately utilizing techniques such as forming, blowing, cutting, and heat sealing. It is also possible to adopt the injection blow molding method. The sheet may be unstretched or stretched, but in consideration of the sealing property, the unstretched state is preferred. In order to prevent blocking between sheets, especially in the above-mentioned multilayer body, when a polymer that easily blocks such as polyethylene is used), roughening (embossing) the inner surface or outer surface of the container, blocking prevention Other polymers, softening agents, inorganic fillers, stabilizers, colorants and the like may be added within the range not impairing the gist of the present invention by adding agents and slip agents. It goes without saying that addition of a styrene-based elastomer such as a block (polystyrene-ethylene butylene copolymer-polystyrene) (SEBS) or a block (polystyrene-ethylene propylene copolymer-polystyrene) (SEPS) is not hindered. INDUSTRIAL APPLICABILITY The present invention is useful as a container for storing blood or blood components, an infusion solution such as physiological saline, an electrolyte solution, a dextran preparation, a mannitol preparation, a saccharide preparation, an amino acid preparation, a fat emulsion, or a container for peritoneal dialysate.
【0009】本発明の医療用容器の応用例として、いわ
ゆる「複室容器」がある。例えば、輸液の場合、アミノ
酸とブドウ糖とを含む液はメイラード反応による変質が
起こりやすいので、各成分を別々の閉鎖系に保存してお
き、患者への投与の直前に混合することが多いが、この
際混合操作を無菌的に(クローズドシステム)行うため
に、また容易に操作するために、複数の収容室に区画さ
れた容器を用い、該収容室の各々に異なる輸液成分を保
存しておき、使用直前に区画された収容室を何らかの手
段でクローズドシステム内で連通させ混合する方法が実
用化されるようになった。ここで使われる容器が複室容
器であり、その一つの方式がイージリィピーラブルタイ
プである。すなわち、収容空間の隔壁部のシールを比較
的安定でかつ混合時(使用時)には容易に破断できる接
着強度としたものである。技術的ポイントは製造時ある
いは輸送時においては収容空間の隔壁シールが比較的安
定で破断しにくく、使用時(混合時)には手、治具など
で容易に破断され得る程度のシール強度を持つ一方、外
界(大気)とつながる境界部(容器周縁部)はこれらの
操作によって破断しない位の大きな強度を示すことであ
る。したがって、容器を形成する材質の選定が重要とな
るのであるが、本発明におけるM−PPはシール強度を
適度に調節でき、透明性、柔軟性も実用的な範囲にある
ので、イージリィピーラブルタイプの複室容器として好
適である。An example of application of the medical container of the present invention is a so-called "multi-chamber container". For example, in the case of infusion, since a liquid containing an amino acid and glucose is likely to be deteriorated due to the Maillard reaction, each component is stored in a separate closed system and often mixed immediately before administration to a patient. At this time, in order to perform the mixing operation aseptically (closed system) and to facilitate the operation, a container divided into a plurality of storage chambers is used, and different infusion components are stored in each of the storage chambers. , A method in which the storage chambers divided just before use are made to communicate with each other in a closed system by some means has been put into practical use. The container used here is a multi-chamber container, one of which is the easily peelable type. That is, the seal of the partition wall of the accommodation space is relatively stable and has an adhesive strength that can be easily broken during mixing (in use). The technical point is that the partition wall seal of the storage space is relatively stable and difficult to break during manufacturing or transportation, and has a sealing strength that can be easily broken by hand, jig, etc. during use (mixing). On the other hand, the boundary portion (peripheral portion of the container) connected to the external environment (atmosphere) has a large strength that is not broken by these operations. Therefore, it is important to select the material forming the container, but the M-PP of the present invention can adjust the seal strength appropriately, and its transparency and flexibility are also in a practical range. It is suitable as a type of multi-chamber container.
【0010】[0010]
【実施例】以下、実施例によって本発明をさらに具体的
に説明する。 (実施例1〜4、比較例1,2) 1−1)実験方法 (1)原料ポリマー:表1に示すポリマーのペレットを
使用した。The present invention will be described more specifically with reference to the following examples. (Examples 1 to 4, Comparative Examples 1 and 2) 1-1) Experimental method (1) Raw material polymer: The polymer pellets shown in Table 1 were used.
【0011】[0011]
【表1】 [Table 1]
【0012】なお、融点は示差走査熱量計(DSC)を
用い、10℃/分の昇温速度で測定した。 (2)シートの作製:(1)のペレットを適宜選択し
て、190〜220℃で溶融し、単層型、2種2層型も
しくは2種3層型のインフレダイから吐出させ(ブロー
アップ比1、2)、水冷リングで冷却後、5m/分の速
度で捲取って、厚さ0.28mm;折径150mmのインフ
レシートを得た。表2にシート構成を示す。 (3)容器の作製:(2)で得られたシートを240mm
長に裁断し、両端を熱シールしてバッグを作製し、生理
食塩水500mlを入れて密封した。 (4)高圧蒸気滅菌テスト:(3)で得られた生理食塩
水入り容器をレトルト型高圧蒸気滅菌機に入れ、温度1
10℃、ゲージ圧1.8kg/cm2、時間60分の条件で処
理した。室温まで冷却後さらに3日間放置し、(5)お
よび(6)の測定用サンプルとした。 (5)シート物性の測定:(4)の3日間放置後の容器
シートを切り取り、波長450nmにおける水中透過率を
島津ダブルビーム型自記分光光度計UV−300にて測
定し、透明性の尺度とした。またJISK7113に準
じて引張弾性率を測定し、柔軟性の尺度とした。 (6)容器(シート)表面の調査:(4)の3日間放置
後の容器表面のべたつき状態を肉眼観察するとともに、
手でさわって調べた。 (7)溶出物試験:日本薬局方一般試験法「輸液用プラ
スチック容器試験法」に準じて、(2)で得られたシー
トについて試験した。The melting point was measured with a differential scanning calorimeter (DSC) at a temperature rising rate of 10 ° C./min. (2) Preparation of sheet: The pellets of (1) are appropriately selected, melted at 190 to 220 ° C., and discharged from a single-layer type, two-kind two-layer type or two-kind three-layer type inflation die (blow-up). After being cooled with a water-cooled ring in a ratio of 1 or 2), it was wound at a speed of 5 m / min to obtain an inflation sheet having a thickness of 0.28 mm and a folding diameter of 150 mm. Table 2 shows the sheet structure. (3) Preparation of container: 240 mm of the sheet obtained in (2)
The bag was cut into a long length, and both ends were heat-sealed to form a bag, and 500 ml of physiological saline was put therein and sealed. (4) High-pressure steam sterilization test: The container containing the physiological saline solution obtained in (3) was placed in a retort type high-pressure steam sterilizer at a temperature of 1
The treatment was carried out under the conditions of 10 ° C., gauge pressure of 1.8 kg / cm 2 , and time of 60 minutes. After cooling to room temperature, it was allowed to stand for another 3 days to obtain measurement samples (5) and (6). (5) Measurement of sheet physical properties: The container sheet after standing for 3 days in (4) was cut out, and the transmittance in water at a wavelength of 450 nm was measured with a Shimadzu double beam type self-recording spectrophotometer UV-300 to obtain a measure of transparency. did. The tensile modulus was measured according to JIS K7113 and used as a measure of flexibility. (6) Investigation of container (sheet) surface: In addition to visually observing the sticky state of the container surface after leaving for 3 days in (4),
I touched it and looked it up. (7) Eluent test: The sheet obtained in (2) was tested according to the Japanese Pharmacopoeia General Test Method “Plastic Container Test Method for Infusion”.
【0013】[0013]
【表2】 [Table 2]
【0014】1−2)実験結果 (1)シートの押出し成形は順調で、いずれも組成にお
いても、異物、発泡、ブロッキングなどは観察されず、
均一なシートが得られた。 (2)実施例1〜5のシートの溶出物は日本薬局方に適
合することが確認された。 (3)表2の「シート(容器)の性質」から次のことが
明らかである。 (イ)融点140℃以下のM−PPを形成層とするシー
トは透明性にすぐれており、高融点M−PP(比較例
1)や通常PP(比較例2)よりも柔軟性に富む。通常
3,000kg/cm2以下の引張弾性率であれば、ソフトバ
ッグとして十分実用性があると言われており、本発明の
容器に用いられたシートはこの要件を満たす。 (ロ)M−PPの分子量分布の狭さを反映してか、容器
(シート)表面にべたつき現象が発生せず、通常PP
(比較例2)の欠点を解消している。なお、比較例2の
場合は表面が濡れていると感じられるほどのべたつき状
態であった。1-2) Experimental results (1) Extrusion molding of the sheet was successful, and no foreign matter, foaming, blocking, etc. were observed in any composition.
A uniform sheet was obtained. (2) It was confirmed that the eluates of the sheets of Examples 1 to 5 were compatible with the Japanese Pharmacopoeia. (3) The following is clear from the "property of the sheet (container)" in Table 2. (A) A sheet having an M-PP forming layer having a melting point of 140 ° C. or less has excellent transparency and is more flexible than the high melting point M-PP (Comparative Example 1) and ordinary PP (Comparative Example 2). It is generally said that the tensile elastic modulus of 3,000 kg / cm 2 or less is sufficiently practical as a soft bag, and the sheet used for the container of the present invention satisfies this requirement. (B) The stickiness phenomenon does not occur on the surface of the container (sheet), probably due to the narrow molecular weight distribution of M-PP, and thus PP
The disadvantage of (Comparative example 2) is solved. In the case of Comparative Example 2, the surface was sticky enough to make the surface feel wet.
【0015】(実施例5、6) 2−1)実験方法 (1)複室容器の作製:実施例2および4で使ったイン
フレシート(それぞれ実施例5および6に対応)を35
0mm長に裁断し、中央部の幅7mmを温度120℃、圧力
2kg/cm2、時間5秒の条件で熱シール後、片方の室にア
ミノ酸3wt/V%水溶液、もう一方の室にブドウ糖15wt
/V%水溶液各300mlを入れ、両端を幅10mm、温度1
60℃、圧力4kg/cm2、時間5秒の条件で熱シール
し、区画室が2個の薬液入り複室容器を作製した。 (2)高圧蒸気滅菌:上記(1)の容器を高圧蒸気滅菌
機に入れ、窒素雰囲気中で、温度110℃、ゲージ圧
1.8kg/cm2、時間30分の条件において滅菌し、室温
まで冷却した。 (3)シール強度の測定:上記(2)の容器を窒素雰囲
気中で3〜5日放置した後、容器の中央部(仕切り部)
および端部(周縁部)のシール部を切り取り、300mm
/分の速度で180°剥離強度を測定、15mm幅の時の
シール強度に換算した(各例についてn=3)。 (4)容器の仕切り部の破断性(連通性)の評価:5日
間放置後の(2)の容器を机の上に寝かせて置き、一方
の区画室側を手で押さえる程度で、仕切り部のシールが
破断するか否かを確認した(各例につき5回テスト)。(Examples 5 and 6) 2-1) Experimental method (1) Preparation of multi-chamber container: The inflation sheet used in Examples 2 and 4 (corresponding to Examples 5 and 6, respectively) was used.
Cut into 0 mm length, heat-seal the width of 7 mm at the center at a temperature of 120 ° C., a pressure of 2 kg / cm 2 , and a time of 5 seconds, then amino acid 3 wt / V% aqueous solution in one chamber and glucose 15 wt in the other chamber.
Put 300ml each of / V% aqueous solution, width 10mm at both ends, temperature 1
Heat sealing was performed under the conditions of 60 ° C., pressure of 4 kg / cm 2 , and time of 5 seconds to prepare a multi-chamber container containing two chemical liquids. (2) High-pressure steam sterilization: The container of (1) above is placed in a high-pressure steam sterilizer and sterilized in a nitrogen atmosphere at a temperature of 110 ° C., a gauge pressure of 1.8 kg / cm 2 , and a time of 30 minutes until room temperature. Cooled. (3) Measurement of seal strength: After the container of (2) above was left in a nitrogen atmosphere for 3 to 5 days, the central part (partition part) of the container
Cut off the seal part at the end and the edge (peripheral part), and
The 180 ° peel strength was measured at a speed of / minute and converted into a seal strength when the width was 15 mm (n = 3 for each example). (4) Evaluation of breakability (communicability) of the partition part of the container: The container of (2) after being left for 5 days is laid on a desk, and the partition part is pressed by one hand with one hand. It was confirmed whether or not the seal of (1) was broken (test was conducted 5 times for each example).
【0016】2−2)実験結果 (1)シール強度:容器の仕切り部のシール強度は実施
例5では0.4〜0.5kg/15mm、実施例6では0.5k
g/15mmであった。また周縁部のシール強度は実施例
5、6ともに2.5〜2.7kg/15mmであった。 (2)容器の仕切り部の破断性(連通性):実施例5お
よび実施例6ともに良好であり、容易に連通させること
ができた。上記(1)のシール強度のデータもこれを裏
付けている。2-2) Experimental results (1) Seal strength: The seal strength of the partition of the container is 0.4 to 0.5 kg / 15 mm in Example 5, and 0.5 k in Example 6.
It was g / 15 mm. In addition, the sealing strength of the peripheral portion was 2.5 to 2.7 kg / 15 mm in both Examples 5 and 6. (2) Breakability (communicability) of the partition part of the container: Both Example 5 and Example 6 were good and could be easily communicated. The data on the seal strength in (1) above also support this.
【0017】[0017]
【発明の効果】以上記載した如く、本発明の医療用容器
は比較的低融点のM−PPを単層シートあるいは多層シ
ートの成分として含むシートにより形成されたものであ
り、該M−PPの良好な透明性と柔軟性が高圧蒸気滅菌
後にも発現すること、従来の低融点PPの問題点も解消
することが明らかとなった。生産性、汎用性にも富むの
で、その工業的価値は高いものがある。As described above, the medical container of the present invention is formed of a sheet containing M-PP having a relatively low melting point as a component of a single-layer sheet or a multi-layer sheet. It was revealed that good transparency and flexibility are exhibited even after high-pressure steam sterilization, and the problems of the conventional low melting point PP are solved. Since it is highly productive and versatile, it has a high industrial value.
Claims (1)
が140℃以下であるポリプロピレンを形成層として含
むシートにより形成されたことを特徴とする医療用容
器。1. A medical container, which is formed of a sheet containing polypropylene as a forming layer, which is produced from a metatheron-based catalyst and has a melting point of 140 ° C. or lower.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7259047A JPH0999036A (en) | 1995-10-05 | 1995-10-05 | Vessel for medical treatment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7259047A JPH0999036A (en) | 1995-10-05 | 1995-10-05 | Vessel for medical treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0999036A true JPH0999036A (en) | 1997-04-15 |
Family
ID=17328601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7259047A Pending JPH0999036A (en) | 1995-10-05 | 1995-10-05 | Vessel for medical treatment |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0999036A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5945187A (en) * | 1996-12-23 | 1999-08-31 | Novo Nordisk A/S | Medicament container of polymer of linear olefin for storing a liquid medicament |
| JP2000178319A (en) * | 1998-12-14 | 2000-06-27 | Mitsubishi Chemicals Corp | Propylene random copolymer for medical container and composition thereof, and medical container |
| WO2012036063A1 (en) | 2010-09-14 | 2012-03-22 | 日本ポリプロ株式会社 | Propylene resin multi-layer sheet, and packaging body for heat treatment using same |
| WO2012036237A1 (en) | 2010-09-17 | 2012-03-22 | 日本ポリプロ株式会社 | Propylene resin sheet and heat processing packaging body using same |
| US8859062B2 (en) | 2009-03-17 | 2014-10-14 | Japan Polypropylene Corporation | Multilayer propylene resin sheet and heat-treatable packaging material using same |
-
1995
- 1995-10-05 JP JP7259047A patent/JPH0999036A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5945187A (en) * | 1996-12-23 | 1999-08-31 | Novo Nordisk A/S | Medicament container of polymer of linear olefin for storing a liquid medicament |
| JP2000178319A (en) * | 1998-12-14 | 2000-06-27 | Mitsubishi Chemicals Corp | Propylene random copolymer for medical container and composition thereof, and medical container |
| US8859062B2 (en) | 2009-03-17 | 2014-10-14 | Japan Polypropylene Corporation | Multilayer propylene resin sheet and heat-treatable packaging material using same |
| WO2012036063A1 (en) | 2010-09-14 | 2012-03-22 | 日本ポリプロ株式会社 | Propylene resin multi-layer sheet, and packaging body for heat treatment using same |
| US8877310B2 (en) | 2010-09-14 | 2014-11-04 | Japan Polypropylene Corporation | Propylene resin multi-layer sheet, and packaging body for heat treatment using same |
| WO2012036237A1 (en) | 2010-09-17 | 2012-03-22 | 日本ポリプロ株式会社 | Propylene resin sheet and heat processing packaging body using same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4209384B2 (en) | Polymer composition comprising a cyclic olefin copolymer | |
| MXPA02005804A (en) | Autoclavable pvc free multilayer film to be especially used for packing liquid, medicinal products, method for producing the same and the use thereof. | |
| WO2002100738A1 (en) | Duplex container | |
| JP4323590B2 (en) | Medical multi-chamber container | |
| JP6434844B2 (en) | Medical multi-chamber container | |
| JP3549643B2 (en) | Medical substrate | |
| JPH0999036A (en) | Vessel for medical treatment | |
| JP3949739B2 (en) | Medical multi-chamber container | |
| JP3973703B2 (en) | Medical multi-chamber container | |
| JP3625497B2 (en) | Medical container base material | |
| JP4363674B2 (en) | Medical multi-chamber container | |
| JP4016049B2 (en) | Medical multi-chamber container | |
| JPH08229099A (en) | Medical double-chamber container | |
| JPH0999037A (en) | Double chamber vessel for medical treatment | |
| JP2016106792A (en) | Medical double-chamber container | |
| JP4119920B2 (en) | Medical multi-chamber container | |
| JPH0956778A (en) | Multi-chamber vessel for medical use | |
| JPH0999035A (en) | Vessel for medical treatment | |
| JP2000197688A (en) | Medical container | |
| JP4906159B2 (en) | Laminated body and medical bag | |
| JPH06169972A (en) | Base material for polyolefin medical care container | |
| JPH06171040A (en) | Polyolefin-based base material for medical container | |
| JPH07125158A (en) | Base material for medical vessel | |
| JPH10263071A (en) | Base material for medical instrument and medical instrument | |
| JPH06169974A (en) | Base material for polyolefin medical care container |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040729 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040921 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041104 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050517 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20051004 |